Company Profile

Structured around improvemen of the lives of those suffering from nerve and muscle disorders through better and early detection and monitoring of diseases, Haystack Diagnostics has an emphasis on enabling early detection of illness using multivariate AI analysis of all biomarkers read out by proteomics. The firm is commercializing needle impedance technology using one the founder's patent. It is estiamted that over 100 million people worldwide are afflicted with one of the many diseases that affect the health of nerves and muscle required for everyday activity. Haystack Diagnostics needle iEMG technology helps both patients and physicians by improving the diagnosis and monitoring of disease progression and therapy effect. The firm's needle iEMG technology and AI-powered software improve reliability and diagnostic capability over current clinical EMG procedure while also provideing trackable health data on the content of the muscle and its internal structure.